研究發展處

Neuroscience

1. Migraine 100%
2. Functional Connectivity 73%
3. Functional Magnetic Resonance Imaging 69%
4. Alzheimer's Disease 68%
5. Headache 67%
6. Magnetic Resonance Imaging 62%
7. Electroencephalography 59%
8. Cognitive Disorders 41%
9. Schizophrenia 41%
10. Major Depressive Disorder 39%
11. Gray Matter Volume 34%
12. Cognitive Function 34%
13. Mild Cognitive Impairment 33%
14. Behavior (Neuroscience) 33%
15. Hippocampus 32%
16. Parkinson's Disease 32%
17. Electroencephalogram 30%
18. Cerebrovascular Accident 28%
19. Brain Region 27%
20. Genetics 26%
21. In Vivo 26%
22. Biological Marker 24%
23. Cognitive Decline 24%
24. Brain Network 23%
25. Default Mode Network 22%
26. Heart Rate Variability 21%
27. Gray Matter 20%
28. Amygdala 20%
29. Blood Plasma 20%
30. Diffusion Tensor Imaging 19%
31. Cluster Headache 18%
32. Thalamus 18%
33. Cerebellum 18%
34. Striatum 18%
35. Antidepressant 16%
36. Attention Deficit Hyperactivity Disorder 16%
37. Older Adults 16%
38. Pervasive Developmental Disorder 15%
39. Receptor 15%
40. Nociception 15%
41. Obstructive Sleep Apnea 15%
42. Human Brain 15%
43. Magnetoencephalography 14%
44. Brain-Derived Neurotrophic Factor 14%
45. Treatment-Resistant Depression 14%
46. Cardiovascular System 14%
47. Voxel-Based Morphometry 14%
48. Prefrontal Cortex 14%
49. Neurodegenerative Disorder 13%
50. Electrotherapy 13%
51. Risk Factor 13%
52. Amyloid Protein 13%
53. Evoked Potential 12%
54. Frontal Lobe 12%
55. Fractional Anisotropy 12%
56. Ketamine 12%
57. Neural Stem Cell 12%
58. Tractography 12%
59. Mental Disorder 12%
60. Brain-Computer Interface 12%
61. Fluorine-18 12%
62. Glutamic Acid 12%
63. Brain Structure 12%
64. Subjective Cognitive Decline 11%
65. Orbitofrontal Cortex 11%
66. Brain Areas 11%
67. Resting-State Functional Connectivity 11%
68. Gamma-Aminobutyric Acid 11%
69. Brain Ischemia 11%
70. Comorbidity 11%
71. Cerebral Cortex 11%
72. Brain Disease 11%
73. Anterior Cingulate Cortex 11%
74. Brain Age 11%
75. Programmed Cell Death 11%
76. Dopaminergic 11%
77. Neural Network 11%
78. Nucleus 10%
79. Brain Function 10%
80. Positron Emission Tomography 10%
81. Depressive Disorder 10%
82. Brain Imaging 10%
83. Somatosensory Cortex 10%
84. Interneuron 10%
85. Hypertension 9%
86. Temporal Lobe 9%
87. In Vitro 9%
88. Neuronal Activity 9%
89. Oxidative Stress 9%
90. Corpus Callosum 9%
91. Sleep Disorder 9%
92. Neuronal Migration 9%
93. Rapid Eye Movement Sleep 9%
94. Brain Development 9%
95. Motor Cortex 9%
96. Transcranial Magnetic Stimulation 9%
97. Cerebrovascular Disease 8%
98. Neurogenesis 8%
99. Autism 8%
100. Gyri 8%

Keyphrases

1. Migraine 80%
2. Taiwan 59%
3. Alzheimer's Disease 52%
4. Alzheime's Disease 50%
5. Chronic Migraine 42%
6. Functional Connectivity 42%
7. Functional Magnetic Resonance Imaging 39%
8. Headache 35%
9. Healthy Controls 35%
10. Taiwanese 35%
11. Gray Matter Volume 34%
12. Major Depressive Disorder 34%
13. Cognitive Function 31%
14. Schizophrenia 30%
15. Cognitive Impairment 29%
16. Reversible Cerebral Vasoconstriction Syndrome 28%
17. Electroencephalography 26%
18. Parkinson's Disease 25%
19. Brain Regions 23%
20. Migraine Patients 22%
21. Cardiac Magnetic Resonance Imaging (cMRI) 21%
22. Magnetoencephalography 21%
23. Hippocampus 21%
24. Older Adults 21%
25. Mild Cognitive Impairment 21%
26. Cluster Headache 21%
27. Dementia 20%
28. Heart Rate Variability 20%
29. Default Mode Network 19%
30. Diffusion Tensor Imaging 18%
31. Obstructive Sleep Apnea 17%
32. Striatum 17%
33. Treatment-resistant Depression 16%
34. Cerebellum 16%
35. National Cohort Study 15%
36. Cognitive Decline 15%
37. 95% Confidence Interval 15%
38. White Matter 15%
39. Autism Spectrum Disorder 15%
40. Neuroimaging 14%
41. Resting State 13%
42. Oxidative Stress 12%
43. Voxel-based Morphometry 12%
44. Episodic Migraine 12%
45. Odds Ratio 12%
46. Primary Dysmenorrhea 12%
47. Attention Deficit Hyperactivity Disorder 12%
48. Amygdala 12%
49. Mini-Mental State Examination 12%
50. Resting-state Functional Magnetic Resonance Imaging 11%
51. Subjective Cognitive Decline 11%
52. Ketamine 11%
53. Electroencephalogram 11%
54. Comorbidity 11%
55. Brain Networks 11%
56. CISD2 11%
57. Brain Aging 11%
58. Aging 11%
59. International Headache Society 11%
60. Brain Structure 11%
61. Antidepressants 11%
62. Single nucleotide Polymorphism 10%
63. Taiwan Biobank 10%
64. Fractional Anisotropy 10%
65. Age-related 10%
66. Menstrual Pain 10%
67. Brain Connectivity 10%
68. Striatal 10%
69. Brain Activity 9%
70. Masticatory Performance 9%
71. White Matter Hyperintensities 9%
72. Proteomic Analysis 9%
73. Fibromyalgia 9%
74. Apoptosis 9%
75. Cortical Neurons 9%
76. Huntington's Disease 9%
77. Brain-computer Interface 9%
78. Brain Development 9%
79. Healthy Adults 9%
80. Hypertension 9%
81. Cortex 8%
82. Neural Correlates 8%
83. Phosphorylation 8%
84. Repetitive Transcranial Magnetic Stimulation (rTMS) 8%
85. Neural Stem Cells 8%
86. Rat Model 8%
87. Hazard Ratio 8%
88. Positron Emission Tomography/computed Tomography (PET/CT) 8%
89. Medication Overuse Headache 8%
90. Anterior Cingulate Cortex 8%
91. Meta-analysis 8%
92. Area under the Curve 8%
93. Comorbid 8%
94. Clinical Trials 8%
95. Sleep Quality 8%
96. Knockdown 8%
97. Transcription Factor 8%
98. Genome-wide Association Study 8%
99. Cerebral Small Vessel Disease (cSVD) 8%
100. Montreal Cognitive Assessment (MoCA) 8%